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Problem Definition
American Academy of Sleep Medicine (AASM) 
recommends all sleep disorders centers (SDC) 
routinely perform urine drug screens (UDS) in 
patients undergoing a multiple sleep latency test 
(MSLT) or maintenance of wakefulness test (MWT) 
to identify substances that can alter results of 
testing.  Many substances can affect the results of 
an MSLT or MST, which influences management of 
sleep disorders going forward. Our research has 
shown most academic SDC have implemented this; 
however, we have not. 
Similar to the SDC that do not check UDS, the 
logistics of administering the screening has been 
the biggest barrier to implementation at our center. 
Aims For Improvement
Aim: 
Goal: To have 100% of patients undergoing an 
MSLT or MWT to have a UDS 
Intervention
Patients who are scheduled to undergo an MSLT or 
MWT will be informed of the UDS as routine 
protocol for these procedures at their office visit.  
They will be given written notice in the after visit 
summary.
Prior to the start of their sleep study procedure, a 
urine specimen will be collected by our lab staff and 
run by the hospital lab as a 7 panel test.  Regardless 
of the outcome of screening, the sleep study will 
proceed. If screening returns positive, this will be 
factored into the interpretation of the study. 
Measurement and Results
The primary goal of this intervention is to establish 
a protocol that meets the standard of care 
recommended by the AASM. An additional 
outcomes will be to evaluate the frequency of 
positive drug tests compared to what patients 
declare they are taking.
Due to COVID-19 the implementation of UDS at 
our SDC has been postponed until the lab returns 
to its normal operations. 
Next Steps and Lessons Learned
Once it is safe to resume in lab sleep studies we will 
begin routine UDS for MSLT and MWT. Input from 
providers, lab personal, and patients will be 
considered when we determine if this intervention 
is a success. 
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Based on data we collected from surveying 
academic SDC, we predict that once implemented, 
the most common positive result will be for 
marijuana (THC) followed by benzodiazepines.  We 
also hypothesize about 15-20% of tests will be 
positive based on the our survey and the current 
literature.  
